| Literature DB >> 31188846 |
Misato Chimura1, Shinichiro Yamada1, Yoshinori Yasaka1, Hiroya Kawai1.
Abstract
The benefit of revascularization of chronic total occlusion (CTO) in percutaneous coronary intervention (PCI) is controversial. On the other hand, left ventricular (LV) global longitudinal strain (GLS) is a more sensitive marker of LV myocardial ischemia and LV function than LV ejection fraction (EF). The purpose of this study was to investigate the impact of revascularization of CTO on LV function using LV GLS. A total of 70 consecutive patients (65.1±8.9 years, 59 males, LVEF 51.0±12.0%) with CTO who had a positive functional ischemia and underwent PCI, were included in this study. Echocardiography was performed before and 9 months after the procedure with conventional assessment including LV end-diastolic and end-systolic volume (LVEDV, LVESV), LVEF, and with 2DSTE analysis of GLS. Successful PCI was obtained in 60 patients (86%). There were no stent thromboses during follow-up. GLS showed a significant improvement 9 months after successful PCI (pre-PCI -12.4±4.1% vs. post-PCI -14.5±4.1%, P< 0.01), whereas in failed PCI group that did not change significantly (pre-PCI -13.2±4.2% vs. post-PCI -14.0±4.7%, P = 0.64). LVEF, LVEDV and LVESV did not change significantly during follow-up in both successful and failed groups. Successful PCI for CTO improved LV function, assessed by LV GLS.Entities:
Mesh:
Year: 2019 PMID: 31188846 PMCID: PMC6561546 DOI: 10.1371/journal.pone.0217092
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Patient flow chart.
Fig 2Example of the measurement of left ventricular (LV) global longitudinal strain (GLS) with a two-dimensional speckle-tracking echocardiography (2DSTE) in a patient with chronic total occlusion who underwent successful percutaneous coronary intervention (PCI).
Figure (a) and (b) showed apical four-chamber view. White broken lines indicated the LV global strain curves for GLS. Yellow arrow indicated the mean LV global peak longitudinal strain; GLS: −22.5% (c).
Patient baseline characteristics.
| All Patients | Successful PCI | Failed PCI | p Value | |
|---|---|---|---|---|
| Demographics | ||||
| Age (years) | 65.1 ± 8.9 | 65.2 ± 9.0 | 64.2 ± 8.6 | 0.74 |
| Male, n (%) | 59 (84) | 51 (85) | 8 (80) | 0.90 |
| Hypertension, n (%) | 64 (91) | 55 (92) | 9 (90) | 0.86 |
| Diabetes Mellitus, n (%) | 40 (57) | 33 (55) | 7 (70) | 0.38 |
| Dyslipidemia, n (%) | 62 (89) | 53 (88) | 9 (90) | 0.89 |
| Smoking, n (%) | 35 (50) | 30 (50) | 5 (50) | 0.66 |
| Systolic BP (mm Hg) | 131 ± 24 | 132 ± 25 | 125 ± 18 | 0.45 |
| Heart rate (beats/min) | 68±11 | 67±11 | 71±14 | 0.30 |
| Laboratory data | ||||
| Serum creatinine (mg/dL) | 1.1 ± 1.0 | 1.1 ± 1.0 | 1.0 ± 0.7 | 0.66 |
| Medications | ||||
| ACEI and/ or ARB, n (%) | 41 (58) | 35 (58) | 6 (60) | 0.92 |
| Beta-blockers, n (%) | 37 (53) | 32 (53) | 5 (50) | 0.85 |
| Nitrates, n (%) | 27 (39) | 22 (37) | 5 (50) | 0.65 |
| Statin, n (%) | 61 (87) | 52 (87) | 9 (90) | 0.78 |
ARB, angiotensin II receptor blocker; ACEI, angiotensin converting enzyme inhibitor; BP, blood pressure; and PCI, percutaneous coronary intervention
Lesion characteristics.
| All Patients | Successful PCI | Failed PCI | p Value | |
|---|---|---|---|---|
| Chronic total occlusion location | ||||
| RCA/LCX/LAD, n (%) | 37/11/22 | 31/10/19 | 6/1/3 | 0.79 |
| Rentrop score (0/1/2/3) | 0/1/60/9 | 0/1/51/8 | 0/0/9/1 | 0.89 |
| Number of treated with stents, n (%) | N/A | 57 (95) | N/A | N/A |
| Number of stents per lesion, n (%) | N/A | 1.5 ± 0.5 | N/A | N/A |
| Stent length, (mm. per stented lesion) | N/A | 38 ± 16 | N/A | N/A |
| Stent thrombosis, n (%) | N/A | 0 (0) | N/A | N/A |
LAD, left anterior descending artery; LCX, left circumflex artery; and RCA, right coronary artery; other abbreviations are as defined in Table 1.
Echocardiographic measures.
| All Patients | Successful PCI | Failed PCI | p Value | |
|---|---|---|---|---|
| Echocardiographic data | ||||
| LVEDV (mL) | 121.9 ± 40.7 | 122.9 ± 39.1 | 116.1 ± 51.2 | 0.63 |
| LVESV (mL) | 57.0 ± 31.9 | 58.5 ± 32.3 | 48.1 ± 30.0 | 0.35 |
| LVEF (%) | 51.0 ± 12.0 | 50.2 ± 12.3 | 55.9 ± 8.9 | 0.11 |
| E/A ratio | 0.72 ± 0.20 | 0.72 ± 0.19 | 0.73 ± 0.21 | 0.85 |
| GLS (%) | -12.2 ± -4.7 | -12.4 ± -4.1 | -13.2 ± -4.2 | 0.47 |
E/A ratio, ratio of early transmitral flow to atrial contraction; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; and LVESV, left ventricular end-systolic volume; other abbreviations are as defined in Tables 1 or 2.
Fig 3Change of LV function from baseline to 9 months after PCI.
GLS in successful PCI group was significantly improved (P<0.01), whereas in failed PCI group that did not change significantly. LVEF showed no significant improvement in both successful and failed PCI groups.
Fig 4Change of LV volume from baseline to 9 months after PCI.
LVEDV and LVESV showed no significant improvement in both successful and failed PCI groups.